Position in STRO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$684,849
+$605,019 QoQ
Shares Held
20,628
+68.0% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 97 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. STRO ranks #158 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in STRO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $684,849 | 20,628 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $79,830 | 122,816 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $233,124 | 126,698 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $413,047 | 119,378 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $340,170 | 116,099 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $532,026 | 94,164 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $392,916 | 91,589 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $318,886 | 91,898 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $416,863 | 89,648 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $391,295 | 84,696 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $628,389 | 77,771 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $393,961 | 70,984 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $326,958 | 62,756 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $453,546 | 55,176 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $832,878 | 55,973 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,043,408 | 55,236 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $989,192 | 53,211 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $665,752 | 29,251 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $601,605 | 27,711 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $206,125 | 20,510 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $145,678 | 18,773 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $140,739 | 13,798 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||